Winthrop Capital Management, LLC

Position in EXEL — Exelixis, Inc.

CIK 2010657 Carmel, IN

Position in EXEL

as of Mar 31, 2026 · filed Apr 28, 2026 Compact

Position Value

$1,115

-$24 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Healthcare · as of Mar 31, 2026

Winthrop Capital Management, LLC holds $153,859 across 5 Biotechnology names. EXEL ranks #5 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CGON	CG Oncology, Inc.	1,467	$99,286
2	EWTX	Edgewise Therapeutics, Inc.	1,377	$43,375
3	PYXS	Pyxis Oncology, Inc.	6,000	$8,760
4	ALNY	Alnylam Pharmaceuticals, Inc.	4	$1,323
5	EXEL	Exelixis, Inc. This page	26	$1,115

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,115	26	0.0%	Shares	Sole	2026-04-28
2025-12-31	$1,139	26	—	Shares	Sole	2026-02-10
No filing history on record for this holder in this stock.